150 related articles for article (PubMed ID: 30978326)
1. Rapid liquid chromatography-tandem mass spectrometry to determine very-long-chain fatty acids in human and to establish reference intervals for the Chinese population.
Wang D; Yu S; Zhang Y; Yin Y; Cheng Q; Xie S; Yu J; Li H; Cheng X; Qiu L
Clin Chim Acta; 2019 Aug; 495():185-190. PubMed ID: 30978326
[TBL] [Abstract][Full Text] [Related]
2. A rapid screening procedure for the diagnosis of peroxisomal disorders: quantification of very long-chain fatty acids, as dimethylaminoethyl esters, in plasma and blood spots, by electrospray tandem mass spectrometry.
Johnson DW
J Inherit Metab Dis; 2000 Jul; 23(5):475-86. PubMed ID: 10947202
[TBL] [Abstract][Full Text] [Related]
3. Detection of unusual very-long-chain fatty acid and ether lipid derivatives in the fibroblasts and plasma of patients with peroxisomal diseases using liquid chromatography-mass spectrometry.
Takashima S; Toyoshi K; Itoh T; Kajiwara N; Honda A; Ohba A; Takemoto S; Yoshida S; Shimozawa N
Mol Genet Metab; 2017 Mar; 120(3):255-268. PubMed ID: 28089346
[TBL] [Abstract][Full Text] [Related]
4. A simple and sensitive liquid chromatographic method for the analysis of free docosanoic, tetracosanoic and hexacosanoic acids in human plasma as fluorescent derivatives.
Chung TC; Kou HS; Chao MC; Ou YJ; Wu HL
Anal Chim Acta; 2008 Mar; 611(1):113-8. PubMed ID: 18298975
[TBL] [Abstract][Full Text] [Related]
5. Plasma C24:0- and C26:0-lysophosphatidylcholines are reliable biomarkers for the diagnosis of peroxisomal β-oxidation disorders.
Morales-Romero B; González de Aledo-Castillo JM; Fernández Sierra C; Martínez Carreira C; Zaragoza Bonet C; Fernández Bonifacio R; Caro Miró MA; Argudo-Ramírez A; López Galera RM; García-Villoria J
J Lipid Res; 2024 Mar; 65(3):100516. PubMed ID: 38320654
[TBL] [Abstract][Full Text] [Related]
6. A new multiplex method for the diagnosis of peroxisomal disorders allowing simultaneous determination of plasma very-long-chain fatty acids, phytanic, pristanic, docosahexaenoic and bile acids by high-performance liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry.
Semeraro M; Rizzo C; Boenzi S; Cappa M; Bertini E; Antonetti G; Dionisi-Vici C
Clin Chim Acta; 2016 Jul; 458():159-64. PubMed ID: 27189059
[TBL] [Abstract][Full Text] [Related]
7. Very-Long-Chain Fatty Acids Quantification by Gas-Chromatography Mass Spectrometry.
Scott AI
Methods Mol Biol; 2022; 2546():501-508. PubMed ID: 36127617
[TBL] [Abstract][Full Text] [Related]
8. Liquid chromatography-tandem mass spectrometry method for estimation of a panel of lysophosphatidylcholines in dried blood spots for screening of X-linked adrenoleukodystrophy.
Natarajan A; Christopher R; Netravathi M; Bhat M; Chandra SR
Clin Chim Acta; 2018 Oct; 485():305-310. PubMed ID: 30018013
[TBL] [Abstract][Full Text] [Related]
9. Fit-for-purpose biomarker LC-MS/MS qualification for the quantitation of very long chain fatty acids in human cerebrospinal fluid.
Williams J; Zhu K; Crampon E; Iffland A
Bioanalysis; 2020 Feb; 12(3):143-158. PubMed ID: 32052644
[No Abstract] [Full Text] [Related]
10. Screening assay of very long chain fatty acids in human plasma with multiwalled carbon nanotube-based surface-assisted laser desorption/ionization mass spectrometry.
Hsu WY; Lin WD; Hwu WL; Lai CC; Tsai FJ
Anal Chem; 2010 Aug; 82(16):6814-20. PubMed ID: 20704371
[TBL] [Abstract][Full Text] [Related]
11. Quantification of Very-Long-Chain and Branched-Chain Fatty Acids in Plasma by Liquid Chromatography-Tandem Mass Spectrometry.
De Biase I; Pasquali M
Methods Mol Biol; 2022; 2546():509-521. PubMed ID: 36127618
[TBL] [Abstract][Full Text] [Related]
12. A pilot study of newborn screening for X-linked adrenoleukodystrophy based on liquid chromatography-tandem mass spectrometry method for detection of C26:0-lysophosphatidylcholine in dried blood spots: Results from 43,653 newborns in a southern Chinese population.
Tang C; Tang F; Cai Y; Tan M; Liu S; Xie T; Jiang X; Huang Y
Clin Chim Acta; 2024 Jan; 552():117653. PubMed ID: 37977233
[TBL] [Abstract][Full Text] [Related]
13. Streamlined determination of lysophosphatidylcholines in dried blood spots for newborn screening of X-linked adrenoleukodystrophy.
Turgeon CT; Moser AB; Mørkrid L; Magera MJ; Gavrilov DK; Oglesbee D; Raymond K; Rinaldo P; Matern D; Tortorelli S
Mol Genet Metab; 2015 Jan; 114(1):46-50. PubMed ID: 25481105
[TBL] [Abstract][Full Text] [Related]
14. Profiles of very-long-chain fatty acids in plasma, fibroblasts, and blood cells in Zellweger syndrome, X-linked adrenoleukodystrophy, and rhizomelic chondrodysplasia punctata.
Schutgens RB; Bouman IW; Nijenhuis AA; Wanders RJ; Frumau ME
Clin Chem; 1993 Aug; 39(8):1632-7. PubMed ID: 8353949
[TBL] [Abstract][Full Text] [Related]
15. Rapid UPLC-MS/MS method for routine analysis of plasma pristanic, phytanic, and very long chain fatty acid markers of peroxisomal disorders.
Al-Dirbashi OY; Santa T; Rashed MS; Al-Hassnan Z; Shimozawa N; Chedrawi A; Jacob M; Al-Mokhadab M
J Lipid Res; 2008 Aug; 49(8):1855-62. PubMed ID: 18441019
[TBL] [Abstract][Full Text] [Related]
16. Stable isotope dilution analysis of very long chain fatty acids in plasma, urine and amniotic fluid by electron capture negative ion mass fragmentography.
Stellaard F; ten Brink HJ; Kok RM; van den Heuvel L; Jakobs C
Clin Chim Acta; 1990 Nov; 192(2):133-44. PubMed ID: 1705871
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a panel of very long-chain lysophosphatidylcholines and acylcarnitines for screening of X-linked adrenoleukodystrophy in China.
Tian GL; Xu F; Jiang K; Wang YM; Ji W; Zhuang YP
Clin Chim Acta; 2020 Apr; 503():157-162. PubMed ID: 31978407
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic patterns of very-long-chain fatty acids in plasma of patients with X-linked adrenoleukodystrophy.
Paik MJ; Kim KR; Yoon HR; Kim HJ
J Chromatogr B Biomed Sci Appl; 2001 Aug; 760(1):149-57. PubMed ID: 11522057
[TBL] [Abstract][Full Text] [Related]
19. Ratios for very-long-chain fatty acids in plasma of subjects with peroxisomal disorders, as determined by HPLC and validated by gas chromatography-mass spectrometry.
Hall NA; Lynes GW; Hjelm NM
Clin Chem; 1988 Jun; 34(6):1041-5. PubMed ID: 2454167
[TBL] [Abstract][Full Text] [Related]
20. Development of a simultaneous quantitation for short-, medium-, long-, and very long-chain fatty acids in human plasma by 2-nitrophenylhydrazine-derivatization and liquid chromatography-tandem mass spectrometry.
Chen Z; Gao Z; Wu Y; Shrestha R; Imai H; Uemura N; Hirano KI; Chiba H; Hui SP
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Sep; 1126-1127():121771. PubMed ID: 31465896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
